FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Georgia Republicans head to runoff in secretary of state race defined by 2020 election claims

Squad-endorsed socialist wins heated primary to represent America’s birthplace

Former top Oregon GOP official secures nomination for governor as Republicans target blue-state pickup

Trump-backed senator cruises to primary win, setting up potential 4th term

Bob Brooks wins Pennsylvania’s 7th District primary to take on Ryan Mackenzie in general election

Three stabbed at crowded Rhode Island beach as hundreds of teens pack area, police say

Bob Harvie wins Pennsylvania’s 1st District primary to set showdown with Brian Fitzpatrick

Trump ally Tommy Tuberville cruises to Alabama GOP governor nomination

Kentucky physician advances to general election after receiving glowing Trump endorsement: ‘True friend’

Pentagon cuts Brigade Combat Teams in Europe as Trump pressures NATO on spending

Stelson-Perry rematch set in Pennsylvania’s 10th District

Gallup Poll: Americans Would Rather Live Near a Nuclear Power Plant Than an AI Data Center

Breaking: Thomas Massie Loses to Trump-Backed Ed Gallrein in Hotly Contested Primary

Tragic: College Football Player Dead at 22, Coach Says ‘He Will Be Sincerely Missed’

Ketanji Brown Jackson Publicly Trashes All 8 of Her Fellow Supreme Court Justices

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”